Pulvinal Beclometasone and Pulvinal Salbutamol dry powder inhalers have been discontinued following a decline in demand.
Stocks of Pulvinal Beclometasone 100, 200 and 400 microgram are expected to run out by the end of 2015. A limited supply of Pulvinal Salbutamol will be available until the middle of January 2016.
Further information
Manufacturer: Chiesi
Healthcare professionals should identify patients currently using these devices and discuss alternatives as soon as possible.
For a guide to available inhalers for the treatment of asthma and COPD, see the asthma and COPD preparations and compatible devices table and the guide to breath-actuated inhalers.